UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Site-Specific Proteasome Inhibitors

Biomolecules (Basel, Switzerland), 2021-12, Vol.12 (1), p.54

Kisselev, Alexei F

2021

Link zum Volltext

Verfügbarkeit prüfen

NEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells

Scientific reports, 2023-03, Vol.13 (1), p.5174-5174, Article 5174

2023

Link zum Volltext

Verfügbarkeit prüfen

Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2

eLife, 2024-04, Vol.12

2024

Link zum Volltext

Verfügbarkeit prüfen

Subunit specific inhibitors of proteasomes and their potential for immunomodulation

Current opinion in chemical biology, 2014-12, Vol.23, p.16-22

2014

Link zum Volltext

Verfügbarkeit prüfen

A clinically relevant pulse treatment generates a bortezomib-resistant myeloma cell line that lacks proteasome mutations and is sensitive to Bcl-2 inhibitor venetoclax

Scientific reports, 2022-07, Vol.12 (1), p.12788-12788, Article 12788

2022

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the Proteasome β2 Site Sensitizes Triple-Negative Breast Cancer Cells to β5 Inhibitors and Suppresses Nrf1 Activation

Cell chemical biology, 2017-02, Vol.24 (2), p.218-230

2017

Link zum Volltext

Verfügbarkeit prüfen

Importance of the Different Proteolytic Sites of the Proteasome and the Efficacy of Inhibitors Varies with the Protein Substrate

The Journal of biological chemistry, 2006-03, Vol.281 (13), p.8582-8590

2006

Link zum Volltext

Verfügbarkeit prüfen

A Novel Bullet Hits the Proteasome

Cancer cell, 2013-12, Vol.24 (6), p.691-693

Kisselev, Alexei F.

2013

Link zum Volltext

Verfügbarkeit prüfen

Certain Pairs of Ubiquitin-conjugating Enzymes (E2s) and Ubiquitin-Protein Ligases (E3s) Synthesize Nondegradable Forked Ubiquitin Chains Containing All Possible Isopeptide Linkages

The Journal of biological chemistry, 2007-06, Vol.282 (24), p.17375-17386

2007

Link zum Volltext

Verfügbarkeit prüfen

Molecular basis of differential sensitivity of myeloma cells to clinically relevant bolus treatment with bortezomib

PloS one, 2013-02, Vol.8 (2), p.e56132-e56132

2013

Link zum Volltext

Verfügbarkeit prüfen

Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL–AF4 fusion protein

Scientific reports, 2021-05, Vol.11 (1), p.1-12, Article 10883

2021

Link zum Volltext

Verfügbarkeit prüfen

The Ubiquitin Ligase Activity in the DDB2 and CSA Complexes Is Differentially Regulated by the COP9 Signalosome in Response to DNA Damage

Cell, 2003-05, Vol.113 (3), p.357-367

2003

Link zum Volltext

Verfügbarkeit prüfen

Monitoring Activity and Inhibition of 26S Proteasomes with Fluorogenic Peptide Substrates

Methods in Enzymology, 2005, Vol.398, p.364-378

2005

Link zum Volltext

Verfügbarkeit prüfen

Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA

The Journal of biological chemistry, 2011-07, Vol.286 (28), p.24882-24895

2011

Link zum Volltext

Verfügbarkeit prüfen

A Set of Activity-Based Probes to Visualize Human (Immuno)proteasome Activities

Angewandte Chemie (International ed.), 2016-03, Vol.55 (13), p.4199-4203

International ed. in English, 2016

Link zum Volltext

Verfügbarkeit prüfen

CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome

Genes & development, 2006-06, Vol.20 (11), p.1429-1434

2006

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based Design of β1i or β5i Specific Inhibitors of Human Immunoproteasomes

Journal of medicinal chemistry, 2014-07, Vol.57 (14), p.6197-6209

2014

Link zum Volltext

Verfügbarkeit prüfen

Structure‐Based Design of Fluorogenic Substrates Selective for Human Proteasome Subunits

Chembiochem : a European journal of chemical biology, 2020-11, Vol.21 (22), p.3220-3224

2020

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits

Journal of medicinal chemistry, 2019-02, Vol.62 (3), p.1626-1642

2019

Link zum Volltext

Verfügbarkeit prüfen

Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation

The Journal of immunology (1950), 2012-08, Vol.189 (4), p.1868-1877

2012

Link zum Volltext

Verfügbarkeit prüfen

The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells

Haematologica (Roma), 2015-10, Vol.100 (10), p.1350

2015

Link zum Volltext

Verfügbarkeit prüfen

DNA-Histone Cross-Links: Formation and Repair

Frontiers in cell and developmental biology, 2020-12, Vol.8, p.607045

2020

Link zum Volltext

Verfügbarkeit prüfen

Incorporation of Non-natural Amino Acids Improves Cell Permeability and Potency of Specific Inhibitors of Proteasome Trypsin-like Sites

Journal of medicinal chemistry, 2013-02, Vol.56 (3), p.1262-1275

2013

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based Design of β5c Selective Inhibitors of Human Constitutive Proteasomes

Journal of medicinal chemistry, 2016-08, Vol.59 (15), p.7177-7187

2016

Link zum Volltext

Verfügbarkeit prüfen

26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide

The EMBO journal, 2001-05, Vol.20 (10), p.2357-2366

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(86)
Dissertationen
(3)

Sprache

Englisch
(89)
Japanisch
(14)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Humans
(41)
Life Sciences & Biomedicine
(41)
Biochemistry & Molecular Biology
(31)
Animals
(25)
Proteasome Endopeptidase Complex - Metabolism
(23)
Proteasome Inhibitors
(21)
Proteasome Endopeptidase Complex
(14)
Proteasome Inhibitors - Pharmacology
(14)
Proteasomes
(13)
Cell Biology
(12)
Molecular Biology
(12)
Substrate Specificity
(12)
Proteasome
(11)
Biochemistry
(10)
Catalytic Domain
(10)
Proteins
(10)
Binding Sites
(9)
Hela Cells
(9)
Mice
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Site-Specific Proteasome Inhibitors

NEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells

Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2

Subunit specific inhibitors of proteasomes and their potential for immunomodulation

A clinically relevant pulse treatment generates a bortezomib-resistant myeloma cell line that lacks proteasome mutations and is sensitive to Bcl-2 inhibitor venetoclax

Inhibition of the Proteasome β2 Site Sensitizes Triple-Negative Breast Cancer Cells to β5 Inhibitors and Suppresses Nrf1 Activation

Importance of the Different Proteolytic Sites of the Proteasome and the Efficacy of Inhibitors Varies with the Protein Substrate

A Novel Bullet Hits the Proteasome

Certain Pairs of Ubiquitin-conjugating Enzymes (E2s) and Ubiquitin-Protein Ligases (E3s) Synthesize Nondegradable Forked Ubiquitin Chains Containing All Possible Isopeptide Linkages

Molecular basis of differential sensitivity of myeloma cells to clinically relevant bolus treatment with bortezomib

Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL–AF4 fusion protein

The Ubiquitin Ligase Activity in the DDB2 and CSA Complexes Is Differentially Regulated by the COP9 Signalosome in Response to DNA Damage

Monitoring Activity and Inhibition of 26S Proteasomes with Fluorogenic Peptide Substrates

Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA

A Set of Activity-Based Probes to Visualize Human (Immuno)proteasome Activities

CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome

Structure-Based Design of β1i or β5i Specific Inhibitors of Human Immunoproteasomes

Structure‐Based Design of Fluorogenic Substrates Selective for Human Proteasome Subunits

Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits

Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation

The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells

DNA-Histone Cross-Links: Formation and Repair

Incorporation of Non-natural Amino Acids Improves Cell Permeability and Potency of Specific Inhibitors of Proteasome Trypsin-like Sites

Structure-Based Design of β5c Selective Inhibitors of Human Constitutive Proteasomes

26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide

Suchergebnisse filtern